pyrazines has been researched along with nadp in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tampo, Y; Tsukamoto, M; Yonaha, M | 1 |
Crause, P; Gloe, T; Keller, M; Pohl, U; Sohn, HY | 1 |
Anastacio, VM; Augusto, O; da Luz, PL; Junqueira, ML; Krieger, JE; Laurindo, FR; Pereira, AC; Souza, HP; Souza, LC | 1 |
Arison, BH; Baillie, TA; Burgey, CS; Lin, JH; Pearson, PG; Silva Elipe, MV; Singh, R; White, R; Wong, BK; Yu, X | 1 |
Begleiter, A; Bird, RP; Curphey, TJ; Sivananthan, K | 1 |
Chapple, S; Collins, C; Fairman, DA | 1 |
Gao, Y; Li, H; Shen, GL; Tan, Y; Zhuang, XM | 1 |
Äänismaa, P; de Kanter, R; Delahaye, S; Gnerre, C; Ichikawa, T; Pfeifer, T; Seeland, S; Segrestaa, J; Treiber, A; Yamada, T | 1 |
Kharechkina, ES; Kruglov, AG; Nikiforova, AB | 1 |
1 trial(s) available for pyrazines and nadp
Article | Year |
---|---|
The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag.
Topics: Acetamides; Acetates; Drug Interactions; Enzyme Inhibitors; Esterases; Hepatocytes; Humans; Membrane Transport Proteins; Metabolic Networks and Pathways; Metabolome; Metabolomics; Microsomes, Liver; NADP; Pyrazines; Receptors, Epoprostenol; Recombinant Proteins; RNA, Messenger | 2018 |
8 other study(ies) available for pyrazines and nadp
Article | Year |
---|---|
Superoxide production from paraquat evoked by exogenous NADPH in pulmonary endothelial cells.
Topics: Animals; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Flavoproteins; Imidazoles; Interleukin-1; Luminescent Measurements; Lung; NAD; NADP; Oxidoreductases; Paraquat; Pyrazines; Spectrophotometry; Succinic Acid; Superoxide Dismutase; Superoxides; Swine; Xanthine | 1999 |
Pitfalls of using lucigenin in endothelial cells: implications for NAD(P)H dependent superoxide formation.
Topics: Acridines; Arsenicals; Cells, Cultured; Cytochrome c Group; Imidazoles; Luminescent Measurements; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Oxidases; Neutrophils; Onium Compounds; Pyrazines; Superoxides; Umbilical Veins; Xanthine; Xanthine Oxidase | 2000 |
Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity.
Topics: Acridines; Animals; Biphenyl Compounds; Catheterization; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Electron Spin Resonance Spectroscopy; Electron Transport; Endothelium, Vascular; Free Radicals; Glutathione; Imidazoles; Lipoxygenase Inhibitors; Luminescent Measurements; Male; Metalloporphyrins; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase; Onium Compounds; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Pyrazines; Rabbits; Reactive Oxygen Species; Recombinant Fusion Proteins; Spin Labels; Superoxide Dismutase; Superoxides; Transcription, Genetic; Wound Healing; Xanthine Oxidase | 2000 |
Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.
Topics: Administration, Oral; Animals; Binding, Competitive; Biotransformation; Carbon Radioisotopes; Epoxy Compounds; Glutathione; Humans; Imines; Microsomes, Liver; NADP; Nuclear Magnetic Resonance, Biomolecular; Oxidation-Reduction; Protease Inhibitors; Protein Binding; Pyrazines; Rats; Spectrometry, Mass, Electrospray Ionization; Thrombin | 2003 |
Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Colon; Colonic Neoplasms; Dimethyl Fumarate; Disease Models, Animal; Enzyme Induction; Fumarates; Glucuronosyltransferase; Glutathione Transferase; Inactivation, Metabolic; Intestinal Mucosa; Liver; Male; NAD(P)H Dehydrogenase (Quinone); NADP; Pyrazines; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Thiones; Thiophenes | 2003 |
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes | 2007 |
[Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes].
Topics: Animals; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Glucuronosyltransferase; Humans; Ligusticum; Microsomes, Liver; NADP; Pyrazines; Rats; Uridine Diphosphate Glucuronic Acid | 2014 |
Pyridine nucleotides regulate the superoxide anion flash upon permeabilization of mitochondrial membranes: An MCLA-based study.
Topics: Animals; Imidazoles; Male; Mitochondrial Membranes; NADP; Permeability; Pyrazines; Pyridines; Rats; Rats, Wistar; Superoxides | 2018 |